The value of cortical stimulation applied to the surgery of malignant gliomas in language areas F. SignorelliJ. GuyotatP. Bret Original Pages: 3 - 10
Neurophysiological classification of ulnar entrapment across the elbow L. PaduaI. AprileP. Tonali Original Pages: 11 - 16
Reversal of CSF positivity for JC virus genome by cidofovir in a patient with systemic lupus erythematosus and progressive multifocal leukoencephalopathy A. SalmaggiE. MaccagnanoM. Savoiardo Case report Pages: 17 - 20
Adult-onset adrenoleukodystrophy: a clinical and neuropsychological study E. LudaM. G. Barisone Case report Pages: 21 - 25
Segmental myoclonus in a patient affected by syringomyelia S. BagnatoV. RizzoP. Girlanda Case report Pages: 27 - 29
Stroke in a young man with fibromuscular dysplasia of the cranial vessels with anticardiolipin antibodies: a case report M. TripathiV. SantoshS. K. Shankar Case report Pages: 31 - 35
Clinical and genetic study of essential tremor in the Italian population G. AbbruzzeseS. PigulloP. Mandich Pages: 39 - 40
Role of dopamine D1 receptors in the control of striatal acetylcholine release by endogenous dopamine E. AcquasG. Di Chiara Pages: 41 - 42
The role of language areas in motor control dysfunction in Parkinson's disease G. AlbaniG. KünigK. L. Leenders Pages: 43 - 44
Perfusion ECD/SPECT in the characterization of cognitive deficits in Parkinson's disease A. AntoniniR. De NotarisG. Pezzoli Pages: 45 - 46
The status of dopamine nerve terminals in Parkinson's disease and essential tremor: a PET study with the tracer [11-C]FE-CIT A. AntoniniR. M. MorescoF. Fazio Pages: 47 - 48
Blockade of subthalamic glutamatergic activity corrects changes in neuronal metabolism and motor behavior in rats with nigrostriatal lesions F. BlandiniJ. T. GreenamyreG. Nappi Pages: 49 - 50
The parkin gene and its phenotype V. BonifatiG. De Michelefor the Italian PD Genetics Study Group, French PD Genetics Study Groupand the European Consortium on Genetic Susceptibility in Parkinson's Disease Pages: 51 - 52
Chronic delusional hallucinatory psychosis in early-onset Parkinson's disease: drug-induced complication or sign of an idiopathic psychiatric illness? A. CannasA. SpissuM. Giagheddu Pages: 53 - 54
Presymptomatic tests in Huntington's disease and dominant ataxias M. CannellaM. SimonelliF. Squitieri Pages: 55 - 56
Chronic bilateral electrical stimulation of the subthalamic nucleus for the treatment of advanced Parkinson's disease L. CapusA. MelatiniS. Zambito Marsala Pages: 57 - 58
Alterations in GAD67, dynorphin and enkephalin mRNA in striatal output neurons following priming in the 6-OHDA model of Parkinson's disease A. CartaS. FenuM. Morelli Pages: 59 - 60
An abnormal striatal synaptic plasticity may account for the selective neuronal vulnerability in Huntington's disease D. CentonzeP. GubelliniP. Calabresi Pages: 61 - 62
Role of striatal acetylcholine on dopamine D1 receptor agonist-induced turning behavior in 6-hydroxydopamine lesioned rats: a microdialysis-behavioral study S. FenuE. AcquasG. Di Chiara Pages: 63 - 64
Decreased platelet glutamate uptake and genetic risk factors in patients with Parkinson's disease C. FerrareseL. TremolizzoL. Frattola Pages: 65 - 66
Deep brain stimulation of the subthalamic nucleus: selection of patients and clinical results L. LopianoM. RizzoneB. Bergamasco Pages: 67 - 68
Proton magnetic resonance spectroscopy (1H-MRS) of motor cortex and basal ganglia in de novo Parkinson's disease patients C. LucettiP. Del DottoU. Bonuccelli Pages: 69 - 70
Interaction between dopamine and adenosine A2A receptors as a basis for the treatment of Parkinson's disease M. MorelliA. Pinna Pages: 71 - 72
The parkin gene is not a major susceptibility locus for typical late-onset Parkinson's disease R. L. OliveriM. ZappiaA. Quattrone Pages: 73 - 74
Amantadine for dyskinesia in patients affected by severe Parkinson's disease C. PaciA. ThomasM. Onofrj Pages: 75 - 76
CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies L. ParnettiA. Lanarifor the Phospho-Tau International Study Group Pages: 77 - 78
Stimulation of growth hormone release in multiple system atrophy, Parkinson's disease and idiopathic cerebellar ataxia M. T. PellecchiaE. SalvatoreA. Filla Pages: 79 - 80
Deep brain stimulation of subthalamic nucleus: behavioural modifications and familiar relations P. PerozzoM. RizzoneL. Lopiano Pages: 81 - 82
Cytogenetic analysis oxidative damage in lymphocytes of Parkinson's disease patients L. PetrozziC. LucettiU. Bonuccelli Pages: 83 - 84
Non-motor effects of deep brain stimulation of the subthalamic nucleus in Parkinson's disease: preliminary physiological results A. PrioriC. CinnanteS. Barbieri Pages: 85 - 86
Which target for DBS in Parkinson's disease? Subthalamic nucleus versus globus pallidus internus A. E. Scotto di LuzioF. AmmannatiP. Mennonna Pages: 87 - 88
Reduced L-dopa absorption and increased clinical fluctuations in Helicobacter pylori-infected Parkinson's disease patients M. PierantozziA. PietroiustiP. Stanzione Pages: 89 - 91
Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: long-term results F. StocchiL. VaccaS. Ruggieri Pages: 93 - 94
Identification of a novel primary torsion dystonia locus (DYT13) on chromosome 1p36 in an Italian family with cranial-cervical or upper limb onset E. M. ValenteA. R. BentivoglioA. Albanese Pages: 95 - 96
Epidemiology of multiple system atrophy N. VanacoreV. Bonifatifor the ESGAP Consortium Pages: 97 - 99
Epidemiology of progressive supranuclear palsy N. VanacoreV. Bonifatifor the ESGAP Consortium Pages: 101 - 103
Unawareness of dyskinesias in Parkinson's and Huntington's diseases C. VitaleM. T. PellecchiaP. Barone Pages: 105 - 106
A PET study with [11-C]raclopride in Parkinson's disease: preliminary results on the effect of amantadine on the dopaminergic system M. A. VolontéR. M. MorescoF. Fazio Pages: 107 - 108
Efficacy and tolerability of dopamine agonists in a parkinsonian population A. ZenzolaC. DiromaG. Iliceto Pages: 109 - 110
